Company intelligence / Profile preview

Novotec Consultores

Sydney, NSW, Australianovotec.es ↗

Ownership: Private
Employees: ~3000
Development stage: Other

Overview

Novotech is a global full-service clinical research organization specializing in accelerating the development of advanced and novel therapeutics for biotech companies. It has supported over 5,000 clinical projects across all phases and indications, with particular expertise in oncology, infectious diseases, neurology, rare diseases, cell & gene therapies, RNA-based therapeutics, ADCs, microbiome therapies and radiopharmaceuticals

Therapeutic areas: OncologyRare DiseasesNeurologyInfectious Diseases
Modalities: Small moleculeMonoclonal antibodyRecombinant proteinVaccineCell therapyRNA therapyAntibody-drug conjugateGene therapy
Industry: Contract Research Organization

Partnerships

Hong Kong-Shenzhen Innovation And Technology Park Limited (HSITPL)5,000+ trial sites globally

Beyond the preview

Go deeper on Novotec Consultores.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novotec Consultores.

Explore the full profile